1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma : anatomical site matters
Westbom-Fremer, Sofia LU
; Tran, Lena
LU
; Ebbesson, Anna
LU
; Martin de la Fuente, Laura
LU
; Jönsson, Jenny-Maria
LU
; Kannisto, Päivi
LU
; Veerla, Srinivas
LU
and Hedenfalk, Ingrid
LU
(2025)
In Cancer Immunology Immunotherapy
74.
- Contribution to journal › Article
-
Mark
High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density
Corvigno, Sara ; Fernebro, Josefin LU ; Karlsson, Josefin Severin ; Mezheieusky, Artur ; Martín-Bernabé, Alfonso ; De La Fuente, Laura Martin LU ; Westbom-Fremer, Sofia LU
; Carlson, Joseph W.
; Klein, Christian
and Kannisto, Paivi
LU
, et al.
(2025)
In Gynecologic Oncology
193.
p.148-155
- Contribution to journal › Article
-
Mark
Copy number signatures in cervical samples enable early detection of high-grade serous ovarian carcinoma
Veerla, Srinivas LU
; Martin de la Fuente, Laura
LU
; Li, Minerva
LU
; Tang, Guyuan
; Ebbesson, Anna
LU
; D'Incalci, Maurizio
; Marchini, Sergio
; Mannarino, Laura
; Måsbäck, Anna
LU
and Malander, Susanne
LU
, et al.
(2025)
SCRM 2025 - the 7th Swedish Cancer Research Meeting
- Contribution to conference › Poster
- 2022
-
Mark
Ovarian Carcinoma - Early Detection and Prognostication
(2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Copy number signatures for early diagnosis of high-grade serous ovarian carcinoma
Martin de la Fuente, Laura LU ; Li, Minerva LU ; Måsbäck, Anna LU ; Malander, Susanne LU
; Kannisto, Päivi
LU
and Hedenfalk, Ingrid
LU
(2022)
“FUTURE PERSPECTIVES IN OVARIAN CANCER RESEARCH”
- Contribution to conference › Poster
- 2021
-
Mark
Detection of Copy Number Aberration and Tumor Fraction in Archival Cervical Specimens from Ovarian Cancer Patients using Shallow Whole Genome Sequencing.
Martin de la Fuente, Laura LU ; Li, Minerva LU ; Veerla, Srinivas LU
and Hedenfalk, Ingrid
LU
(2021)
- Contribution to conference › Poster
-
Mark
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
Bååth, Maria LU ; Jönsson, Jenny-Maria LU ; Westbom Fremer, Sofia LU
; Martin de la Fuente, Laura
LU
; Tran, Lena
LU
; Malander, Susanne
LU
; Kannisto, Päivi
LU
; Måsbäck, Anna
LU
; Honeth, Gabriella
LU
and Hedenfalk, Ingrid
LU
(2021)
In Genes
12(5).
- Contribution to journal › Article
- 2020
-
Mark
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
Martin de la Fuente, Laura LU ; Westbom-Fremer, Sofia LU
; Arildsen, Nicolai Skovbjerg
LU
; Hartman, Linda
LU
; Malander, Susanne
LU
; Kannisto, Päivi
LU
; Måsbäck, Anna
LU
and Hedenfalk, Ingrid
LU
(2020)
In Virchows Archiv: an international journal of pathology
477(1).
p.83-91
- Contribution to journal › Article
-
Mark
SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery
Bååth, Maria LU ; Westbom-Fremer, Sofia LU
; Martin de la Fuente, Laura
LU
; Ebbesson, Anna
LU
; Davis, Juliette
; Malander, Susanne
LU
; Måsbäck, Anna
LU
; Kannisto, Päivi
LU
and Hedenfalk, Ingrid
LU
(2020)
In Molecular and Cellular Oncology
7(6).
- Contribution to journal › Article
-
Mark
High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer
Corvigno, Sara ; Mezheyeuski, Artur ; De La Fuente, Laura Martin LU ; Westbom-Fremer, Sofia LU
; Carlson, Joseph W.
; Fernebro, Josefin
LU
; Åvall-Lundqvist, Elisabeth
; Kannisto, Paivi
LU
; Hedenfalk, Ingrid
LU
and Malander, Susanne
LU
, et al.
(2020)
In Gynecologic Oncology
159(3).
p.860-868
- Contribution to journal › Article